Trial
NCT04331067
Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
Bristol-Myers Squibb
Condition
Triple Negative Breast Cancer
Intervention
Paclitaxel
Why stopped
BMS terminated the study
Provenance
Dataset: 2026-07-10 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-09